Fred G. Weiss
Director/Board Member chez The Michael J. Fox Foundation for Parkinson's Research
Profil
Fred G.
Weiss is currently the Director at The Michael J.
Fox Foundation for Parkinson's Research and the Managing Director at Fgw Consultancy LLC.
He previously served as Vice Chairman at BlackRock CoRI Funds from 2013 to 2017, Independent Director at Actavis, Inc. from 2011 to 2013, Director at BTG Ltd.
from 2001 to 2007, and Independent Director at Allergan Ltd.
(Ireland) from 2000 to 2018.
He was also the Managing Director at FGW Associates, Inc. and an Independent Non-Executive Director at RVL Pharmaceuticals Plc from 2018 to 2021.
Prior to these roles, he was the VP-Planning, Investment & Development at Warner-Lambert Co. from 1979 to 1996.
Mr. Weiss received his undergraduate degree from the University of Pennsylvania and his MBA from The University of Chicago.
Postes actifs de Fred G. Weiss
Sociétés | Poste | Début |
---|---|---|
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | Director/Board Member | 01/01/2000 |
Fgw Consultancy LLC | Corporate Officer/Principal | - |
Anciens postes connus de Fred G. Weiss
Sociétés | Poste | Fin |
---|---|---|
RVL PHARMACEUTICALS PLC | Director/Board Member | 04/11/2021 |
ALLERGAN PLC | Director/Board Member | 31/10/2018 |
BlackRock CoRI Funds
BlackRock CoRI Funds Investment Trusts/Mutual FundsMiscellaneous BlackRock CoRI Funds operates as a Open-End Investment Fund/Trust. The Trust currently offers shares of five series: BlackRock CoRI 2015 Fund, BlackRock CoRI 2017 Fund, BlackRock CoRI 2019 Fund, BlackRock CoRI 2021 Fund and BlackRock CoRI 2023 Fund. It was founded on July 26, 2013 and is headquartered in Wilmington, DE. | Director/Board Member | 01/01/2017 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Director/Board Member | 01/10/2013 |
BTG | Director/Board Member | 01/01/2007 |
Formation de Fred G. Weiss
University of Pennsylvania | Undergraduate Degree |
The University of Chicago | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
RVL PHARMACEUTICALS PLC | Health Technology |
Entreprise privées | 8 |
---|---|
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | Health Technology |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Health Technology |
BlackRock CoRI Funds
BlackRock CoRI Funds Investment Trusts/Mutual FundsMiscellaneous BlackRock CoRI Funds operates as a Open-End Investment Fund/Trust. The Trust currently offers shares of five series: BlackRock CoRI 2015 Fund, BlackRock CoRI 2017 Fund, BlackRock CoRI 2019 Fund, BlackRock CoRI 2021 Fund and BlackRock CoRI 2023 Fund. It was founded on July 26, 2013 and is headquartered in Wilmington, DE. | Miscellaneous |
BTG Ltd.
BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
FGW Associates, Inc. | |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | Commercial Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Fgw Consultancy LLC |